Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians
Open Access
- 7 February 2017
- journal article
- research article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (31) , 50792-50803
Abstract
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Raphael Saffroy1, 2, Jean-François Morère2, 3, Nelly Bosselut1, 2, Pasquale F. Innominato3, 4, 5, 6, Jocelyne Hamelin1, 2, Jean Trédaniel7, Sophie Masse8, Véronique Dussaule-Duchatelle9, André Balaton9, 10, Pierre Validire11, Catherine Guettier12, Mohamed Bouchahda3, 13 and Antoinette Lemoine1, 2 1AP-HP, GH Paris-Sud, Hôpital Paul Brousse, Department of Biochiemistry and Oncogenetics, Platform Oncomolpath/INCa, Villejuif, France 2INSERM UMR-S 1193, Université Paris-Sud, Université Paris-Saclay, Villejuif, France 3AP-HP, GH Paris-Sud, Hôpital Paul Brousse, Department of Medical Oncology, Villejuif, France 4INSERM UMR-935, Université Paris-Sud, Hôpital Paul Brousse, Villejuif, France 5Cancer Chronotherapy Unit, Cancer Research Centre, Warwick Medical School, University of Warwick, Coventry, United Kingdom 6Department of Oncology, Queen Elizabeth Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom 7Hôpital Saint Joseph, Department of Respiratory Medicine, Université Paris 5, Paris, France 8Groupe Hospitalier Nord Essonne, Department of Pathology, Longjumeau, France 9Hôpital Saint Joseph, Department of Pathology, Paris, France 10ACP Bievres-les Ulis, Department of Pathology, Les Ulis, France 11Institut Mutualiste Montsouris, Department of Pathology, Paris, France 12AP-HP, GH Paris-Sud, Hôpital Paul Brousse, Department of Pathology, Platform Oncomolpath/INCa, Villejuif, France 13Ramsay-GDS Clinique du Mousseau, Department of Medical Oncology, Evry, France Correspondence to: Antoinette Lemoine, email: antoinette.lemoine@aphp.fr Keywords: NSCLC, genetic testing, genotype, EGFR, ERBB2 Received: November 01, 2016 Accepted: January 09, 2017 Published: February 07, 2017Keywords
This publication has 54 references indexed in Scilit:
- Updated Frequency of EGFR and KRAS Mutations in NonSmall-Cell Lung Cancer in Latin America: The Latin-American Consortium for the Investigation of Lung Cancer (CLICaP)Journal of Thoracic Oncology, 2015
- NSCLC and HER2: Between Lights and ShadowsJournal of Thoracic Oncology, 2014
- Smoking status and self-reported race affect the frequency of clinically relevant oncogenic alterations in non-small-cell lung cancers at a United States-based academic medical practiceLung Cancer, 2013
- Genotyping Non-small Cell Lung Cancer (NSCLC) in Latin AmericaJournal of Thoracic Oncology, 2011
- Phosphoinositide-3-Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- Screening for Epidermal Growth Factor Receptor Mutations in Lung CancerNew England Journal of Medicine, 2009
- Second-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung CancerJournal of Thoracic Oncology, 2008
- Mutations within the tyrosine kinase domain of EGFR gene specifically occur in lung adenocarcinoma patients with a low exposure of tobacco smokingBritish Journal of Cancer, 2006
- The Relationship between Epidermal Growth Factor Receptor Mutations and Clinicopathologic Features in Non–Small Cell Lung CancersClinical Cancer Research, 2005
- EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic TreatmentJournal of Clinical Oncology, 2005